Fact CheckerSign in

NCT06636526Recruiting

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups.

Source: ClinicalTrials.gov · Last updated 4 Feb 2026

Brief summary (registry, in English)

The i4i PRODICT® study has been developed to investigate the uptake and acceptability of the i4i PRODICT® test which combines both common and rare genetic changes (genetic variants) into one saliva-based DNA test to estimate a person's future risk of prostate cancer (PrCa) in people of varying ethnicities.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1000 (estimated)
First submitted
7 Oct 2024
Start date
2 Jun 2025
Primary completion date
1 Dec 2028
Lead sponsor
Institute of Cancer Research, United Kingdom
NCT number
NCT06636526

What you commit to

  • Study type: Observational
  • Planned participants: 1000
  • From 2 Jun 2025 to the primary completion date, 1 Dec 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous diagnosis of prostate cancer.
  • Previous diagnosis of cancer with a life-expectancy of less than five years.

Other illness

  • Any significant psychological conditions that may be worsened or exacerbated by participation in the study.

Other

  • People of mixed ancestry
  • Negative prostate biopsy within one year before recruitment.

Who the study is looking for

  • People with a prostate\* (PwP). \*People with a prostate is defined as people born male.
  • Aged 40 to 55 years.
  • People of either (i) Black African/Black African-Caribbean; (ii) White European; or (iii) South Asian or East Asian ancestry. These are defined as individuals with 4 grandparents of the same ancestry.
  • Absence of any psychological, familial, sociological or geographical situation potentially hampering compliance with the study protocol and follow-up schedule.

Age in the registry: 40 years to 55 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Royal Marsden Hospital
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
The Royal Marsden Hospital
Coordinator of this site? Confirm its status
SuttonUnited KingdomRecruiting
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Coordinator of this site? Confirm its status
SuttonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.